Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples